1-11 of 11
Ivan D. Horak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity

Helle J. Jacobsen, Thomas T. Poulsen, Anna Dahlman, Ida Kjær, Klaus Koefoed, Jette W. Sen, Dietmar Weilguny, Bolette Bjerregaard, Christina R. Andersen, Ivan D. Horak, Mikkel W. Pedersen, Michael Kragh, Johan Lantto
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (18): 4110–4122.
DOI: https://doi.org/10.1158/1078-0432.CCR-14-3312
Published: 14 September 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor

Fabio Pastorino, Monica Loi, Puja Sapra, Pamela Becherini, Michele Cilli, Laura Emionite, Domenico Ribatti, Lee M. Greenberger, Ivan D. Horak, Mirco Ponzoni
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19): 4809–4821.
DOI: https://doi.org/10.1158/1078-0432.CCR-10-1354
Published: 29 September 2010
View article
PDF
Journal Articles

Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11–Refractory Model

Puja Sapra, Hong Zhao, Mary Mehlig, Jennifer Malaby, Patricia Kraft, Clifford Longley, Lee M. Greenberger, Ivan D. Horak
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (6): 1888–1896.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-4456
Published: 17 March 2008
View article
PDF
Journal Articles

Therapeutic Advantage of Pretargeted Radioimmunotherapy Using a Recombinant Bispecific Antibody in a Human Colon Cancer Xenograft

Habibe Karacay, Pierre-Yves Brard, Robert M. Sharkey, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride, Dan R. Ragland, Ivan D. Horak, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7879–7885.
DOI: https://doi.org/10.1158/1078-0432.CCR-05-1246
Published: 08 November 2005
View article
PDF
Journal Articles

Pretargeting of Carcinoembryonic Antigen–Expressing Cancers with a Trivalent Bispecific Fusion Protein Produced in Myeloma Cells

Edmund A. Rossi, Chien-Hsing Chang, Michele J. Losman, Robert M. Sharkey, Habibe Karacay, William McBride, Thomas M. Cardillo, Hans J. Hansen, Zhengxing Qu, Ivan D. Horak, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 7122s–7129s.
DOI: https://doi.org/10.1158/1078-0432.CCR-1004-0020
Published: 03 October 2005
View article
PDF
Journal Articles

Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods

Robert M. Sharkey, Habibe Karacay, Thomas M. Cardillo, Chien-Hsing Chang, William J. McBride, Edmund A. Rossi, Ivan D. Horak, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 7109s–7121s.
DOI: https://doi.org/10.1158/1078-0432.CCR-1004-0009
Published: 03 October 2005
View article
PDF
Journal Articles

Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys

Puja Sapra, Rhona Stein, Jennifer Pickett, Zhengxing Qu, Serengulam V. Govindan, Thomas M. Cardillo, Hans J. Hansen, Ivan D. Horak, Gary L. Griffiths, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (14): 5257–5264.
DOI: https://doi.org/10.1158/1078-0432.CCR-05-0204
Published: 20 July 2005
View article
PDF
Journal Articles

Advantage of a Residualizing Iodine Radiolabel in the Therapy of a Colon Cancer Xenograft Targeted with an Anticarcinoembryonic Antigen Monoclonal Antibody

Rhona Stein, Serengulam V. Govindan, Marianne Hayes, Gary L. Griffiths, Hans J. Hansen, Ivan D. Horak, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2727–2734.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-2100
Published: 06 April 2005
View article
PDF
Journal Articles

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

Rhona Stein, Zhengxing Qu, Susan Chen, Adriane Rosario, Victoria Shi, Marianne Hayes, Ivan D. Horak, Hans J. Hansen, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (8): 2868–2878.
DOI: https://doi.org/10.1158/1078-0432.CCR-03-0493
Published: 20 April 2004
View article
PDF
Journal Articles

Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate

Gary L. Griffiths, M. Jules Mattes, Rhona Stein, Serengulam V. Govindan, Ivan D. Horak, Hans J. Hansen, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (17): 6567–6571.
Published: 24 December 2003
View article
PDF
Journal Articles

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer

Susan J. Knox, Michael L. Goris, Margaret Tempero, Paul L. Weiden, Louis Gentner, Hazel Breitz, Gregory P. Adams, Donald Axworthy, Sally Gaffigan, Kyle Bryan, Darrell R. Fisher, David Colcher, Ivan D. Horak, Louis M. Weiner
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 406–414.
Published: 01 February 2000
View article
PDF